ClinicalTrials.govpublic full text
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
breast atypical ductal hyperplasia, breast atypical lobular hyperplasia, breast carcinoma, breast ductal carcinoma in situ, breast lobular carcinoma in situ, estrogen receptor-positive breast carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 901916
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.